Source:http://linkedlifedata.com/resource/pubmed/id/12004257
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Suppl
|
pubmed:dateCreated |
2002-5-10
|
pubmed:abstractText |
This article aims to address the predictable impact of genetics on the design of clinical trials in the field of critical care medicine, with emphasis on the pathophysiology of sepsis and its treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0090-3493
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S341-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
2002
|
pubmed:articleTitle |
The era of genomics: impact on sepsis clinical trial design.
|
pubmed:affiliation |
Medical Intensive Care Unit and Cochin Institute of Molecular Genetics, Cochin-St Vincent de Paul University Hospital, Paris, France.
|
pubmed:publicationType |
Journal Article,
Review
|